Preterm Labor Clinical Trial
Official title:
Extended Release Nifedipine Treatment as Maintenance Tocolysis to Prevent Preterm Delivery:A Prospective Interventional Study
Verified date | December 2010 |
Source | The Baruch Padeh Medical Center, Poriya |
Contact | n/a |
Is FDA regulated | No |
Health authority | Israel:IRB Commission (local) |
Study type | Interventional |
To evaluate the treatment efficacy and safety usig extended release nifedipine, as
maintenance therapy to pregnant women who were hospitalized and treated for preterm labor
until 34 weeks' gestation. After the PTL will stop, we will randomize these women for the
treatment group and the control (no treatment) group.
The main outcome will be preterm delivery before 34 weeks' gestation. the secondary outcome
will be the side effects of the medication and the newborn/mother health variables.
Status | Terminated |
Enrollment | 0 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: - pregnancy week 24-33 - Singleton pregnancy - After successful treatment to stop PTL Exclusion Criteria: - Contraindications for Nifedipine extended release treatment. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
The Baruch Padeh Medical Center, Poriya |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06168149 -
The Relationship of Fetal Lung Elastography Values With the Development of Respiratory Distress in Cases of Preterm Labor
|
||
Completed |
NCT02538718 -
Efficacy and Safety of MgSO4 as Tocolytics Compared to Ritodrine in Preterm Labor
|
N/A | |
Not yet recruiting |
NCT05864066 -
Cyclin-dependent Kinase Inhibitor 2A (Placental Senescence Marker) on Labor-related Signals
|
||
Terminated |
NCT03715530 -
Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women
|
N/A | |
Recruiting |
NCT03638037 -
Correlation Between Maternal Vitamin D Level And Preterm Birth
|
||
Recruiting |
NCT03992534 -
The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth
|
Phase 1 | |
Withdrawn |
NCT03122704 -
Group B Streptococcus (GBS) Infection and in Preterm Labor Women Conceived Through IVF
|
N/A | |
Completed |
NCT02536352 -
Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being
|
Early Phase 1 | |
Recruiting |
NCT01518816 -
Role of Serum Total Antioxidant Level in Preterm Labor
|
N/A | |
Recruiting |
NCT04590677 -
Prediction of the Onset of Term and Preterm Labour
|
||
Completed |
NCT03112018 -
Strengthening Facility-based Intrapartum/Immediate Newborn Care to Reduce Mortality of Preterm Infants in Migori County, Kenya and Busoga Region, Uganda
|
N/A | |
Active, not recruiting |
NCT04301518 -
Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs
|
N/A | |
Completed |
NCT03785795 -
Multichannel EMG Diagnosing True Preterm Labor
|
||
Withdrawn |
NCT02351310 -
Effectiveness of ACS in Extreme Preemies
|
Phase 3 | |
Not yet recruiting |
NCT01985594 -
Utrogestan Versus Nifedipine as Tocolysis for Preterm Labor: a Randomised Controlled Trial
|
Phase 2 | |
Not yet recruiting |
NCT04532086 -
Uterocervical Angle and Preterm Labour
|
||
Completed |
NCT04605172 -
Lockdown Impact on Spontaneous Premature Birth in a Level III NICU
|
||
Recruiting |
NCT04417595 -
Investigating N-3 Fatty Acids to Prevent Neonatal Tobacco-related outcomeS
|
Phase 2 | |
Completed |
NCT03923023 -
Impact of the PREEMI Package on Neonatal Mortality
|
||
Recruiting |
NCT06157203 -
Labor Status Monitor for Diagnosing True vs False Labor in Preterm Patients
|